Creator Fund — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Biophoundry develops phage-based technologies for therapeutics, diagnostics, and bio-molecular engineering, including its Phax platform aimed at making phage therapy faster and more affordable.
AI & Machine LearningBiotechHealthtechChapel Hill, US
Rani Brooks(CEO & Co-Founder)inSahan B.W. Liyanagedera(Executive Officer, Director)
BoardLouis Marlow(Director)
Fairgen offers a marketplace of "digital twins" — simulated survey respondents built from real panel and research data — that product, marketing, and insights teams can query or run structured studies against to get directional customer insights in minutes.
AI & Machine LearningMarketing TechSaaSTel Aviv, IL
Benny Schnaider(Founder)in
Co-investorsIGNIAMaverick Ventures IsraelTal Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.